Clinical Trial Update: Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery [Phase 1]

View source ↗

Summary

A Phase 1 trial tested the combination of tremelimumab and durvalumab in patients with colorectal cancer with liver metastases that are resectable; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Carcinoma in the Liver, Resectable Mass | Phase 1 | Status: COMPLETED | Results posted: 2024-10-09